Use of Lugol's iodine in the resection of oral and oropharyngeal squamous cell carcinoma.
We evaluated the use of Lugol's iodine in achieving surgical margins free from dysplasia, carcinoma in situ, and invasive carcinoma by an observational study of two series of 50 consecutive patients having resection of oral and oropharyngeal squamous cell carcinoma (SCC) between November 2004 and March 2007. The standard group had resection of the primary tumour with a macroscopic 1cm margin and removal of adjacent visibly abnormal mucosa. The Lugol's iodine group had identical treatment with resection of any adjacent mucosa that did not stain after the application of Lugol's iodine (where this was feasible). In the standard group 16 patients (32%) had dysplasia, carcinoma in situ, or invasive SCC at a surgical margin. In the Lugol's iodine group two patients (4%) had dysplasia or carcinoma in situ; none had invasive SCC. Lugol's iodine is a simple, inexpensive, and apparently effective means of reducing the likelihood of unsatisfactory surgical margins in the resection of oral and oropharyngeal SCC.
McMahon
Jeremy
J
Regional Maxillofacial Unit Southern General Hospital, 1345 Govan Road Glasgow, G51 4TF, UK.
Devine
John C
JC
McCaul
James A
JA
McLellan
Douglas R
DR
Farrow
Adrian
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000601:surgery*; D016009:Chi-Square Distribution; D004396:Coloring Agents; D005260:Female; D006801:Humans; D007454:Iodides; D007972:Leukoplakia, Oral / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology / Q000601:surgery; D009062:Mouth Neoplasms / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009959:Oropharyngeal Neoplasms / Q000601:surgery*
D004396:Coloring Agents; D007454:Iodides; C010389:Lugol's solution